[Fatal encephalomyelitis after or because of N1-sulfanilyl-N2-n-butylcarbamide therapy of a diabetes case].
D002271:Carbutamide; D003920:Diabetes Mellitus / Q000628:therapy*; D004679:Encephalomyelitis / Q000209:etiology*; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000031:analogs & derivatives; D014508:Urea / Q000031:analogs & derivatives
D013424:Sulfanilamides; D000077145:Sulfanilamide; D014508:Urea; D002271:Carbutamide
DIABETES MELLITUS/therapy; ENCEPHALOMYELITIS/etiology and pathogenesis; SULFANILAMIDE/related compounds; UREA/related compounds
Letal verlaufende Encephalomyelitis post- oder propter N1-sulfanilyl-N2-n-butylcarbamid-Therapie eines Diabetes?